Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic mastectomy.

Shaheen Zakaria1, Amy C Degnim

  • 1Department of Surgery, Mayo Clinic and Mayo Foundation, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

The Surgical Clinics of North America
|May 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi‑scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune‑cold field phenotype associated with breast cancer risk.

Breast cancer research : BCR·2026
Same author

The Human Male Mammary Gland has Similar Epithelial Populations to Female but Distinct Composition and Transcriptional Properties.

bioRxiv : the preprint server for biology·2026
Same author

Epidermal Growth Factor Receptor/KIT-Linked Proliferative Bias in Normal Breast Lobules from Matched Non-Hispanic Black and White Women Is Rapidly Reversible by Receptor Tyrosine Kinase Inhibition.

The American journal of pathology·2026
Same author

Tissue Microarray-Based Digital Spatial Profiling of Benign Breast Lobules and Breast Cancers: Feasibility, Biological Coherence, and Cross-Platform Benchmarks.

Cancers·2025
Same author

A STAT1-GBP1 axis modulates epithelial proliferation in postpartum breast tissue by repressing CDKI expression.

Breast cancer research : BCR·2025
Same author

High-resolution microCT to assess breast microcalcification morphometry by histologic lesion subtype and radiologic classification.

Breast cancer research and treatment·2025
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Prophylactic mastectomy (PM) may be considered for high-risk women, including BRCA gene carriers, to reduce breast cancer risk. However, PM remains controversial due to a lack of randomized controlled trials on its benefits and harms.

Area of Science:

  • Oncology
  • Genetics
  • Preventive Medicine

Background:

  • Increased identification of high-risk women for breast cancer through genetic testing and risk stratification models.
  • Availability of various risk-reducing options: surveillance, chemoprevention, prophylactic salpingo-oophorectomy (PSO), and prophylactic mastectomy (PM).

Purpose of the Study:

  • To identify high-risk women who may benefit from prophylactic mastectomy (PM).
  • To summarize existing data on the efficacy of PM in breast cancer prevention.

Main Methods:

  • Review of current literature and data on prophylactic mastectomy.
  • Identification of patient populations most likely to benefit from PM.

Main Results:

  • BRCA gene carriers and women with a strong family history are primary candidates for PM.

Related Experiment Videos

  • Prophylactic mastectomy (PM) efficacy data is summarized, but randomized controlled trials are lacking.
  • Conclusions:

    • Prophylactic mastectomy (PM) is a consideration for select high-risk women.
    • The benefits and harms of PM require further investigation through rigorous clinical trials.